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Abstract
Background—Data on risk associated with 24-hour ambulatory diastolic (DBP24) versus 
systolic (SBP24) blood pressure are scarce.
Methods and Results—We recorded 24-hour blood pressure and health outcomes in 8341 
untreated people (mean age, 50.8 years; 46.6% women) randomly recruited from 12 populations. 
We computed hazard ratios (HRs) using multivariable-adjusted Cox regression. Over 11.2 years 
(median), 927 (11.1%) participants died, 356 (4.3%) from cardiovascular causes, and 744 (8.9%) 
experienced a fatal or nonfatal cardiovascular event. Isolated diastolic hypertension (DBP24≥80 
mm Hg) did not increase the risk of total mortality, cardiovascular mortality, or stroke (HRs≤1.54; 
P≥0.18), but was associated with a higher risk of fatal combined with nonfatal cardiovascular, 
cardiac, or coronary events (HRs≥1.75; P≤0.0054). Isolated systolic hypertension (SBP24≥130 
mm Hg) and mixed diastolic plus systolic hypertension were associated with increased risks of all 
aforementioned end points (P≤0.0012). Below age 50, DBP24 was the main driver of risk, 
reaching significance for total (HR for 1-SD increase, 2.05; P=0.0039) and cardiovascular 
mortality (HR, 4.07; P=0.0032) and for all cardiovascular end points combined (HR, 1.74; 
P=0.039) with a nonsignificant contribution of SBP24 (HR≤0.92; P≥0.068); above age 50, SBP24 
predicted all end points (HR≥1.19; P≤0.0002) with a nonsignificant contribution of DBP24 
(0.96≤HR≤1.14; P≥0.10). The interactions of age with SBP24 and DBP24 were significant for all 
cardiovascular and coronary events (P≤0.043).
Conclusions—The risks conferred by DBP24 and SBP24 are age dependent. DBP24 and isolated 
diastolic hypertension drive coronary complications below age 50, whereas above age 50 SBP24 
and isolated systolic and mixed hypertension are the predominant risk factors.
Keywords
ambulatory blood pressure monitoring; blood pressure component; cardiovascular diseases; 
population
Hypertension remains the predominant driver of cardiovascular disease. In 2001, 
hypertension caused 8 million deaths worldwide, representing 14% of global mortality.1 In 
an individual-subject meta-analysis of close to 1 million people, the risk of coronary heart 
disease and stroke gradually increased with blood pressure from levels as low as 115 mm Hg 
systolic and 75 mm Hg diastolic.2 The Framingham investigators3,4 and other researchers5 
showed in studies published as early as 1971 that diastolic pressure was the strongest 
predictor of coronary heart disease below age 50 with an increase in the importance of 
systolic blood pressure with advancing age.
Using blood pressure levels of 140 mm Hg systolic and 90 mm Hg diastolic, current 
guidelines subdivide hypertension on conventional sphygmomanometry into isolated 
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diastolic, isolated systolic, and diastolic combined with systolic (mixed) hypertension.6 
Several population studies have demonstrated that isolated diastolic hypertension confers a 
cardiovascular risk that was intermediate between normotension and isolated systolic or 
mixed hypertension.7,8 Compared with conventional sphygmomanometry, ambulatory blood 
pressure monitoring substantially refines risk stratification.9 To our knowledge, no previous 
study has assessed the risks associated with isolated diastolic, isolated systolic, and mixed 
hypertension on 24-hour ambulatory monitoring or examined the age dependency of 24-hour 
diastolic and systolic ambulatory blood pressure as independent risk factors in the general 
population. We addressed these issues by analyzing the International Database on 
Ambulatory blood pressure in relation to Cardiovascular Outcomes (IDACO).10
Methods
Study Population
At the time of writing this report, the IDACO database10 included 12 randomly recruited 
population cohorts11–20 and 12 711 participants with available data on the conventional and 
ambulatory blood pressure. All participants gave informed written consent. We excluded 
participants if they were younger than 18 years (n=303), if they were taking antihypertensive 
drugs at baseline (n=2144), or if they had <10 daytime or 5 nighttime blood pressure 
readings (n=1923). Thus, the number of subjects included in the present analysis totaled 
8341. (for details, see the Expanded Methods and Table I in the online-only Data 
Supplement).
Blood Pressure Measurement
Methods used for conventional and ambulatory blood pressure measurement are described in 
detail in the Expanded Methods in the online-only Data Supplement. Conventional blood 
pressure was the average of 2 consecutive readings. Portable monitors were programmed to 
obtain ambulatory blood pressure readings at 30-minute intervals throughout the whole 
day,12,19 or at intervals ranging from 1511,17,18 to 3012,19 minutes during daytime and from 
3011,12,17–19 to 6014 minutes at night. To categorize levels of the ambulatory blood pressure, 
we followed the guidelines of the European Societies of Cardiology and Hypertension.6 
Ambulatory hypertension was a 24-hour level of ≥130 mm Hg systolic or ≥80 mm Hg 
diastolic. Using these thresholds, we categorized participants as being normotensive, or as 
having isolated diastolic, isolated systolic, or mixed hypertension on 24-hour ambulatory 
monitoring.
Other Measurements
We used the questionnaires originally administered in each cohort to obtain information on 
each participant’s medical history and smoking and drinking habits. Body mass index was 
body weight in kilograms divided by height in meters squared. We measured serum 
cholesterol and blood glucose by automated enzymatic methods. Diabetes mellitus was the 
use of antidiabetic drugs, a fasting glucose of ≥7.0 mmol/L,21 a random glucose of ≥11.1 
mmol/L,21 a self-reported diagnosis, or diabetes mellitus documented in practice or hospital 
records.
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Ascertainment of Events
We ascertained vital status and the incidence of fatal and nonfatal diseases from the 
appropriate sources in each country, as described in previous publications.10,22 In most 
cohorts,11–18 information on vital status was obtained, even if participants dropped out from 
follow-up. Outcomes were coded according to the international classification of diseases, as 
described in the Expanded Methods in the online-only Data Supplement. Fatal and nonfatal 
stroke did not include transient ischemic attacks. Coronary events encompassed death from 
ischemic heart disease, sudden death, nonfatal myocardial infarction, and coronary 
revascularization. Cardiac events comprised coronary end points and fatal and nonfatal heart 
failure. Hospitalizations for unstable angina were coded as ischemic heart disease. In the 
Danish11 and Swedish14 cohorts, the diagnosis of heart failure required admission to 
hospital. In the other cohorts,12,13,15–20 heart failure was either a clinical diagnosis or the 
diagnosis on the death certificate, but in all cases it was validated against hospital files or the 
records held by family doctors. The composite cardiovascular end point included all 
aforementioned end points plus cardiovascular mortality. In analyses of fatal combined with 
nonfatal outcomes, we only considered the first event within each disease cluster.
Statistical Analysis
For database management and statistical analysis, we used SAS software, version 9.3 (SAS 
Institute, Cary, NC). Missing data were imputed using cohort- and sex-specific regression 
equations with age as explanatory variable (for details, see the Expanded Methods and Table 
II in the online-only Data Supplement). We tabulated the incidence of end points by blood 
pressure status on ambulatory measurement. We computed 95% confidence intervals (CIs) 
of rates as R±1.96 × √(R/T), where R and T are the rate and the denominator used to 
calculate the rate. We compared means and rates using the large-sample z test and 
proportions by the χ2 statistic, respectively. We plotted the incidence of end points across 
categories of the ambulatory blood pressure, using Cox models standardized to the sex 
distribution and mean age in the whole study population. We compared hazard ratios (HRs) 
between categories of the ambulatory blood pressure using the Wald χ2 statistic.
In multivariable-adjusted Cox regression analyses, we accounted for cohort, sex, age, body 
mass index, smoking and drinking, serum cholesterol, history of cardiovascular disease, and 
diabetes mellitus. To adjust for cohort, we pooled participants recruited in the European 
Project on Genes in Hypertension (Kraków, Novosibirsk, Padova, and Pilsen).18 We 
ascertained that the proportional hazard assumption was fulfilled by testing the interaction 
between blood pressure and follow-up time. We compared hazard ratios between subgroups 
according to age, sex, or ethnicity, using the appropriate interaction terms. To assess the 
prognostic significance of diastolic blood pressure at different levels of systolic blood 
pressure, and vice versa, we modeled the 10-year absolute risk of a composite 
cardiovascular end point using Cox regression, while standardizing to the average of the 
distributions in the whole study population (mean or ratio) of cohort, sex, age, body mass 
index, smoking and drinking, serum cholesterol, history of cardiovascular disease, and 
diabetes mellitus. Statistical significance was a α-level <0.05 on 2-sided tests.
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Results
Baseline Characteristics
The 8341 participants included 5489 Europeans (65.8%), 1280 Asians (15.3%), and 1572 
South Americans (18.9%), and 3888 women (46.6%). Age ranged from 18 to 94 years and 
averaged (±SD) 50.8±15.8 years. At enrollment, 2474 participants (29.7%) were smokers 
and 4061 (48.7%) reported intake of alcohol. In the whole study population, conventional 
blood pressure averaged (±SD) 128.7±21.4 mm Hg systolic and 78.6±11.3 mm Hg diastolic, 
whereas the 24-hour ambulatory blood pressure was 122.1±13.5 mm Hg systolic and 
73.1±8.2 mm Hg diastolic.
Table 1 shows the participants’ baseline characteristics by categories of the 24-hour 
ambulatory blood pressure. Normotensive participants and patients with isolated diastolic 
hypertension had similar characteristics except for the proportion of women (52.6 versus 
36.5%) and drinkers (45.0 versus 54.4%), and body mass index (24.5 versus 25.9 kg/m2) 
and serum cholesterol (5.48 versus 5.67 mmol/L). Patients with mixed or isolated systolic 
hypertension were older, more obese, had higher serum cholesterol and blood glucose levels, 
and were more likely to be diabetic than those with isolated diastolic hypertension (Table 1). 
The proportions of isolated diastolic, isolated systolic, and mixed hypertension were 5.9%, 
3.9%, and 6.1%, respectively, among younger participants (aged <50 years), whereas the 
corresponding frequencies were 4.1%, 16.3%, and 18.4% among older adults (aged ≥50 
years).
Incidence of Events
In the whole study population, median follow-up was 11.2 years (5th to 95th percentile 
interval, 2.5 –18.2). Across cohorts, median follow-up ranged from 2.5 years (2.3–2.6) in 
Jingning to 17.2 years (5.3–20.4) in Noorderkempen. During 92 379 person-years of follow-
up, 927 participants died (10.0 per 1000 person-years) and 744 experienced a fatal or 
nonfatal cardiovascular event (8.25 per 1000 person-years). Mortality included 356 
cardiovascular and 548 non-cardiovascular deaths and 23 deaths from unknown cause. 
Considering cause-specific first cardiovascular events, the incidence of fatal and nonfatal 
stroke amounted to 78 and 203, respectively. Cardiac events consisted of 216 fatal and 425 
nonfatal events, including 90 fatal and 141 nonfatal cases of acute myocardial infarction, 
122 deaths from ischemic heart disease, 56 sudden deaths, 37 fatal and 140 nonfatal cases of 
heart failure, and 71 cases of surgical or percutaneous coronary revascularization.
Risk by Categories of Ambulatory Blood Pressure
Median years of follow-up (5th to 95th percentile interval) amounted to 11.4 (2.6–18.3), 9.7 
(2.4–18.2), 11.0 (2.7–17.3), and 10.8 (2.5–17.8) in normotensive individuals and in patients 
with isolated diastolic, isolated systolic, and mixed hypertension, respectively. Table 2 
shows that the incidence rates were similar (P≥0.13) in normotensive participants and in 
patients with isolated diastolic hypertension except for cardiac end points (3.1 versus 5.9 
events per 1000 person-years; P=0.021) and coronary events (2.2 versus 4.6 events per 1000 
person-years; P=0.024). Compared with isolated diastolic hypertension, event rates were 
higher (P<0.001) in patients with mixed or isolated systolic hypertension. After 
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standardization to the sex distribution (46.6% women) and mean age (50.8 years) in the 
whole study population, the incidence of a composite cardiovascular end point gradually 
increased from normotension, over isolated diastolic hypertension onto isolated systolic and 
mixed hypertension (Figure 1). Detailed information on the number of participants at risk, 
those retained in the analysis, and those with a cardiovascular (Table III in the online-only 
Data Supplement) or cardiac (Table IV in the online-only Data Supplement) end point is 
available by 2-year intervals in the online Data Supplement.
In further multivariable-adjusted analyses with normotension as reference (Table 3), isolated 
diastolic hypertension did not increase the risk of total and cardiovascular mortality or stroke 
(HRs ≤1.54; P≥0.18), but was associated with a higher risk of a composite cardiovascular 
end point and of fatal combined with nonfatal cardiac and coronary events (HRs ≥1.75; 
P≤0.0054). With normotension as reference, both mixed and isolated systolic hypertension 
were associated with an increased risk of all end points under study (P≤0.0012) with the 
exception of noncardiovascular mortality (P≥0.096). The HRs were significantly higher 
(P≤0.046) in patients with mixed hypertension than in those with isolated systolic 
hypertension, except for fatal combined with nonfatal cardiac (P=0.065) and coronary 
events (P=0.17).
Risks Associated with Diastolic and Systolic Blood Pressures
In line with previous publications based on the conventionally measured blood pressure,4–6 
we stratified our multivariable-adjusted analyses by age group (<50 and ≥50 years, Table 4). 
Median years of follow-up (5th to 95th percentile interval) amounted to 12.1 (2.5–18.6) and 
11.1 (2.6–17.6) in younger and older participants, respectively. In younger participants, in 
fully adjusted models, which included both diastolic and systolic blood pressure, diastolic 
blood pressure predicted total (HR for 1-SD increase, 2.05; P=0.0039) and cardiovascular 
mortality (HR, 4.07; P=0.0032) and the composite cardiovascular end point (HR, 1.74; 
P=0.039), whereas 24-hour systolic blood pressure was not significantly associated with 
these end points (HR, ≤0.92; P≥0.068; Table 4). In older participants, systolic pressure 
predicted total and cardiovascular mortality and all of the end points combining fatal with 
nonfatal events (HR, ≥1.19; P≤0.0002), whereas diastolic pressure did not significantly 
predict any outcome (0.96≤HR≤1.14; P≥0.10). Analyses based on daytime (Table V in the 
online-only Data Supplement) or nighttime (Table VI in the online-only Data Supplement) 
blood pressure, or restricted to the 7949 subjects free of cardiovascular disease at baseline 
(Table VII in the online-only Data Supplement), or excluding 1 cohort at a time (Table VIII 
in the online-only Data Supplement), confirmed the results given in Table 4. Compared with 
the conventional blood pressure, 24-hour diastolic and systolic pressure retained their 
predictive superiority in all participants (Table IX in the online-only Data Supplement) as 
well as in categories based on blood pressure status on conventional measurement (online-
only Data Supplement, pages 5–6).
Next, based on the data given in Table 4, we tested the interactions of 24-hour systolic and 
diastolic blood pressures with age, ethnicity, and sex. Using age as a continuous variable, 
the interaction terms with diastolic and systolic pressure in fully adjusted models were 
significant or borderline significant for cardiovascular mortality (0.036≤P≤0.058), the 
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composite cardiovascular end point (0.0037≤P≤0.0048), and coronary events 
(0.012≤P≤0.043). When excluding 1 cohort at a time (Table VIII in the online-only Data 
Supplement), the interactions with age consistently retained significance for the composite 
cardiovascular end point (0.0009≤P≤0.050). For cardiovascular mortality and coronary 
events the interactions of age with systolic and diastolic blood pressure remained formally or 
borderline significant (0.0079≤P≤0.093), but lost significance for cardiovascular mortality 
after excluding Ohasama, Jingning, or Noorderkempen (0.12≤P≤0.20) and for coronary 
events with Montevideo removed (0.10≤P≤0.15). The hazard ratios associated with systolic 
and diastolic blood pressure were similar in Asians and whites (Table X in the online-only 
Data Supplement). As reported previously,22 the hazard ratios associated with 24-hour 
systolic blood pressure were higher in women than men (Table XI in the online-only Data 
Supplement) for all cardiovascular end points (P≤0.019) with the exception of 
cardiovascular mortality (P=0.079) and stroke (P=0.64). For 24-hour diastolic blood 
pressure, the fully adjusted hazard ratios were similar in women and men (P≥0.45).
Finally, we used Cox regression to model the 10-year absolute risk of a composite 
cardiovascular end point in relation to 24-hour diastolic pressure at different levels of 24-
hour systolic pressure and vice versa. Figure 2 shows that the 10-year risk of fatal combined 
with nonfatal cardiovascular events increased (P<0.001) with 24-hour diastolic pressure 
irrespective of the level of systolic pressure. Risk also increased with the 24-hour systolic 
pressure independent of the 24-hour diastolic pressure.
Discussion
Our analysis included 8341 untreated people randomly recruited from 12 populations and 
covered on average >11 years of follow-up (median). The key finding was that the risks 
conferred by diastolic and systolic blood pressure as measured by noninvasive 24-hour 
ambulatory monitoring were age dependent. Diastolic pressure and isolated diastolic 
hypertension were the drivers of coronary complications, in particular below age 50 years, 
whereas above age 50 years systolic pressure and isolated systolic and mixed hypertension 
became the predominant determinants of risk.
Systolic pressure increases with age until the eighth decade of life.23 By contrast, diastolic 
pressure rises only until 50 years of age, after which it becomes steady or even slightly 
decreases.23 In the Framingham Heart Study,3,4 increasing age entailed a shift from diastolic 
to systolic pressure as the main predictor of cardiovascular risk. Below age 50 years, 
diastolic pressure was the strongest predictor, whereas the opposite occurred above 50 years 
of age. Khattar and colleagues used intra-arterial ambulatory blood pressure monitoring in 
688 untreated hypertensive patients and obtained similar findings.24 Our current study, 
based on noninvasive 24-hour ambulatory blood pressure monitoring and the analysis of 
cause-specific outcomes in general populations, consolidated these findings.
Several studies based on conventional sphygmomanometry25–27 or on the self-measured 
blood pressure at home28 reported that isolated diastolic hypertension confers low 
cardiovascular risk, in particular at young age. The Honolulu Heart Program25 reported on 
8006 Japanese-American men followed for 20 years. Cutoff levels for diastolic and systolic 
Li et al. Page 7
Circulation. Author manuscript; available in PMC 2015 April 29.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
hypertension were levels of 90 and 160 mm Hg, respectively. For men aged 45 to 54 years, 
the relative risks compared with normotension were 1.4 (95% CI, 1.0–2.1), 4.3 (2.9–6.3), 
and 4.8 (2.1–11.0) for isolated diastolic, mixed, and isolated systolic hypertension.25 For 
men aged 55 to 68 years, the corresponding hazard ratios were 1.8 (1.3–2.5), 1.7 (1.2–2.4), 
and 1.2 (0.7–2.0), respectively.25 Fang and colleagues26 used the same blood pressure 
criteria as the Honolulu investigators to categorize systolic and diastolic hypertension in 
1560 participants (<60 years) in a worksite hypertension control program. Over 4.5 years of 
follow-up, 24 participants got a myocardial infarction (3.9 events per 1000 person-years). 
The rate was higher in the patients with mixed hypertension than in those with isolated 
diastolic hypertension (5.2 versus 2.2 per 1000 patient-years).26 No myocardial infarction 
occurred in participants with diastolic hypertension and a systolic blood pressure <140 mm 
Hg.26 Strandberg and coworkers recruited 3267 initially healthy Finnish men, aged 30 to 45 
years, and followed mortality for up to 32 years.27 With normotension as reference (blood 
pressure <160 mm Hg systolic and <90 mm Hg diastolic), the hazard ratios for mortality 
were 2.71 (2.00–3.66) in patients with mixed hypertension, but only 1.39 (1.04–1.87) or 
1.14 (0.77–1.69) in patients with isolated diastolic hypertension and systolic pressure 
between 140 and 160 mm Hg or <140 mm Hg, respectively.27
The Ohasama investigators28 followed 1913 participants aged 40 or older (average 61 years) 
for 8 years. The blood pressure thresholds based on home blood pressure were 137 mm Hg 
systolic and 84 mm Hg diastolic. The cardiovascular death rate was similar (0.33 versus 0.26 
deaths per 100 person-years) in normotensive participants and in those with isolated 
diastolic hypertension. Patients with mixed or isolated systolic hypertension on self-
measurement at home had significantly elevated death rates amounting to 1.11 and 2.04 per 
100 person-years, respectively.
Several subject-level meta-analyses2,7,8 addressed the role of systolic and diastolic blood 
pressure or various subtypes of hypertension as cardiovascular risk factors. All were based 
on conventional sphygmomanometry. Kelly and colleagues7 did a prospective cohort study 
(from 1991 until 2000) in a nationally representative sample of 169 577 Chinese women and 
men, aged 40 years or more. These investigators used blood pressure levels of 90 mm Hg 
diastolic and 140 mm Hg systolic to classify subjects. Compared with normotension, relative 
risks of cardiovascular disease incidence and mortality were 2.73 (2.60–2.86) and 2.53 
(2.39–2.68) for combined systolic and diastolic hypertension, 1.78 (1.69–1.87) and 1.68 
(1.58–1.78) for isolated systolic hypertension, and 1.59 (1.43–1.76) and 1.45 (1.27–1.65) for 
isolated diastolic hypertension.7 The Asia Pacific Cohort Studies Collaboration8 studied 346 
570 participants from 36 cohort studies. Outcomes were fatal and nonfatal cardiovascular 
disease. In multivariable-adjusted Cox regression, with normal blood pressure (<80 mm Hg 
diastolic and 120 mm Hg systolic) as the reference, hazard ratios were 1.81 (1.61–2.04), 
2.18 (2.00–2.37), and 3.42 (3.17–3.70) for isolated diastolic, isolated systolic, and mixed 
hypertension, respectively.8 The Prospective Studies Collaboration2 demonstrated in 958 
074 participants (61 cohort studies) that at ages 40 to 69 years, each 20-mm Hg increase in 
systolic blood pressure or 10-mm Hg increase in diastolic blood pressure was associated 
with more than a doubling in the death rates of stroke, ischemic heart disease, or other 
vascular death. These findings in subject-level meta-analyses with a large sample size are in 
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keeping with our current study that made use of ambulatory blood pressure monitoring 
instead of conventional sphygmomanometry.
Our findings argue against the suggestion to abandon diastolic pressure measurement and to 
rely only on systolic blood pressure for the management of hypertension.29 Moreover, 
reversibility of the risk by blood pressure lowering treatment in patients with isolated 
diastolic hypertension30 confirms that certainly in younger individuals diastolic blood 
pressure is a risk factor that must be treated. The prevalence of isolated diastolic 
hypertension on 24-hour ambulatory blood pressure measurement was 4.9% in the whole 
untreated IDACO cohort and 17.2% among untreated patients with ambulatory 
hypertension. In the National Health Examination Survey (NHES) and National Health and 
Nutrition Examination Survey (NHANES) studies, 6% to 9% of subjects with elevated 
blood pressure readings had an isolated elevation of diastolic blood pressure with a normal 
systolic blood pressure.31
Our current study has some potential limitations. First, the number of end points in some 
subgroups was relatively small, in particular in the younger age group, in whom healthy 
elastic arteries might lead to a relatively less elevated systolic than diastolic blood pressure. 
Diastolic blood pressure is the driving force in the coronary circulation. This constellation 
might explain why diastolic hypertension is a risk factor for premature coronary heart 
disease and therefore for cardiac events below age 50. Second, patients with diastolic or 
mixed hypertension can progress to isolated systolic hypertension, so called burned-out 
hypertension, because with aging large arteries stiffen, so that systolic blood pressure rises 
and diastolic blood pressure falls. Our categorical analyses did not account for this 
phenomenon. Finally, we could not adjust for the serum lipid profile over and beyond total 
serum cholesterol, because too few participants had measurements of low-density or high-
density cholesterol. We also did not account for measures of renal function, because they 
were only available in 4808 of our participants. However, we previously demonstrated that 
the incremental predictive value of renal function in an epidemiological setting is small 
compared with the 24-hour ambulatory blood pressure.32 Other factors we did not account 
for include family history of heart disease, and use of medications after enrolment.
In conclusion, we show that the risks conferred by diastolic and systolic blood pressure on 
24-hour ambulatory measurement are age dependent. The 24-hour diastolic blood pressure 
and isolated diastolic hypertension drive coronary complications below age 50, whereas 
above age 50 the 24-hour systolic blood pressure is the predominant risk factor.
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CLINICAL PERSPECTIVE
No previous study has assessed the risks associated with isolated diastolic, isolated 
systolic, and mixed hypertension on 24-hour ambulatory monitoring or examined the age 
dependency of 24-hour systolic and diastolic ambulatory blood pressures as independent 
risk factors in the general population. In 8341 untreated people (mean age, 50.8 years; 
46.6% women) randomly recruited from 12 populations and followed up for a median of 
11.2 years, the risks conferred by diastolic and systolic ambulatory blood pressure were 
age dependent. Ambulatory diastolic pressure and isolated diastolic hypertension drove 
coronary complications below age 50 years, whereas above 50 years of age 24-hour 
systolic pressure and isolated systolic and mixed hypertension were the predominant 
determinants of risk. Our findings argue against the suggestion to abandon diastolic 
pressure measurement and to rely only on systolic pressure for the management of 
hypertension. Moreover, in younger individuals elevated diastolic pressure as assessed by 
24-hour ambulatory monitoring is a risk factor that must be treated.
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Figure 1. 
Incidence of the composite cardiovascular (CV) end point (A) and fatal combined with 
nonfatal cardiac events (B) in 4 categories of the ambulatory blood pressure. Incidence was 
standardized to the sex distribution (46.6% women) and mean age (50.8 years) in the whole 
study population. For each blood pressure category, the number of subjects at risk is given at 
the beginning of each 4-year interval. The time axis was curtailed at 16 years when ≈10% of 
participants were still being followed up. Tables III and IV in the online-only Data 
Supplement provide more detailed information by 2-year intervals up to 22 years on the 
number of participants at risk, the number of events, and the number of participants no 
longer followed up. Vertical bars denote the standard error. P values are for the differences 
across the 4 blood pressure categories.
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Figure 2. 
Ten-year absolute risk of a composite cardiovascular (CV) end point associated with 24-
hour diastolic blood pressure (DBP, A) and 24-hour systolic blood pressure (SBP, B) in 
participants with normal (full line) or elevated (dashed line) systolic pressure (A) or normal 
or elevated diastolic pressure (B) on ambulatory measurement. The cut-off points for 24-
hour hypertension were ≥130 mm Hg systolic and ≥80 mm Hg diastolic, respectively. For 
each risk function, the number (n) of subjects contributing to the risk function is given. In 
the Cox regression models, 10-year absolute risk was standardized to the average of the 
distributions in the whole study population (mean or ratio) of cohort, sex, age, body mass 
index, smoking and drinking, serum cholesterol, history of cardiovascular disease, and 
diabetes mellitus. Ne indicates the number of events in each group. P values denote the 
significance of the independent contribution of diastolic pressure (A) or systolic pressure 
(B).
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Table 1
Baseline Characteristics of Participants by Categories of 24-Hour Ambulatory Blood Pressure
Characteristic Normotension Isolated Diastolic Hypertension Mixed Hypertension Isolated Systolic Hypertension
Number of subjects 5969 408 1071 893
 European, (%) 3908 (65.5)‡ 221 (54.2) 720 (67.2)‡ 640 (71.7)‡
 Asian, (%) 983 (16.5) 55 (13.5) 140 (13.1) 102 (11.4)
 South American, (%) 1078 (18.1)‡ 132 (32.4) 211 (19.7)‡ 151 (16.9)‡
 Women, (%) 3141 (52.6)‡ 149 (36.5) 315 (29.4)† 283 (31.7)
 Smokers, (%) 1741 (29.2) 132 (32.4) 348 (32.5) 253 (28.3)
 Drinking alcohol, (%) 2684 (45.0)‡ 222 (54.4) 652 (60.9)† 503 (56.3)
 Diabetes mellitus, (%) 266 (4.5) 23 (5.6) 89 (8.3) 92 (10.3)†
 Cardiovascular disorders, (%) 243 (4.1) 23 (5.6) 59 (5.5) 67 (7.5)
Mean characteristic (SD)
 Age, y 47.9 (15.7) 48.7 (11.4) 58.0 (12.0)‡ 62.3 (13.8)‡
 Body mass index, kg/m2 24.5 (3.9)‡ 25.9 (4.2) 26.6 (4.2)† 26.5 (4.4)*
 Conventional blood pressure
  Systolic, mm Hg 121.7 (16.3) 131.5 (13.2) 151.3 (22.8) 146.8 (22.8)
  Diastolic, mm Hg 75.1 (9.3) 86.6 (8.2) 92.0 (10.9) 82.0 (10.3)
 24-hour blood pressure
  Systolic, mm Hg 115.7 (7.9) 124.5 (4.0) 143.6 (11.4) 137.6 (7.8)
  Diastolic, mm Hg 69.6 (5.3) 82.9 (2.7) 87.2 (6.0) 74.5 (4.1)
 Blood glucose, mmol/L 5.03 (1.17) 5.11 (1.25) 5.44 (1.66)† 5.45 (1.64)†
 Serum cholesterol, mmol/L 5.48 (1.13)† 5.67 (1.13) 5.78 (1.14) 5.86 (1.14)†
Hypertension was a 24-hour ambulatory blood pressure ≥130 mm Hg or 80 mm Hg diastolic. Mixed hypertension refers to diastolic combined with 
systolic hypertension. Significance of the difference with isolated diastolic hypertension:
*
P≤0.05;
†
P≤0.01; and
‡
P≤0.001. Significance levels were not calculated for blood pressure values, used to categorize participants.
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Table 2
Incidence of End Points by Categories of 24-Hour Ambulatory Blood Pressure
End Point Normotension Isolated Diastolic Hypertension Mixed Hypertension Isolated Systolic Hypertension
Number of participants 5969 408 1071 893
Total mortality
 Number of deaths 493 25 204 205
 Rate 7.3 (6.6–7.9) 6.0 (3.6–8.3) 18.3 (15.8–20.8)‡ 22.0 (19.0–25.0)‡
Cardiovascular mortality
 Number of deaths 151 11 101 93
 Rate 2.2 (1.9–2.6) 2.6 (1.1–4.2) 9.1 (7.3–10.8)‡ 10.0 (7.9–12.0)‡
Noncardiovascular mortality
 Number of deaths 328 14 100 106
 Rate 4.8 (4.3–5.4) 3.4 (1.6–5.1) 9.0 (7.2–10.7)‡ 11.4 (9.2–13.5)‡
All cardiovascular events
 Number of events 329 28 200 187
 Rate 4.9 (4.4–5.5) 6.8 (4.3–9.4) 18.9 (16.3–21.5)‡ 21.1 (18.1–24.1)‡
Cardiac events
 Number of events 211 24 124 118
 Rate 3.1 (2.7–3.6)* 5.9 (3.5–8.2) 11.5 (9.5–13.5)‡ 13.1 (10.7–15.4)‡
Coronary events
 Number of events 151 19 91 87
 Rate 2.2 (1.9–2.6)* 4.6 (2.5–6.7) 8.3 (6.6–10.0)‡ 9.5 (7.5–11.5)‡
Stroke
 Number of events 106 5 76 69
 Rate 1.6 (1.3–1.9) 1.2 (0.1–2.3) 7.0 (5.4–8.6)‡ 7.6 (5.8–9.3)‡
Hypertension was a 24-hour ambulatory blood pressure ≥130 mm Hg systolic or 80 mm Hg diastolic. Incidence rates reflect the number of events 
per 1000 person-years. Significance of the difference with isolated diastolic hypertension:
*
P≤0.05; and
‡
P≤0.001.
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<
0.
00
01
Ca
rd
ia
c 
(47
7)
1.
96
 (1
.28
–3
.01
)
0.
00
22
2.
16
 (1
.72
–2
.73
)
<
0.
00
01
1.
70
 (1
.34
–2
.16
)
<
0.
00
01
Co
ro
na
ry
 (3
48
)
2.
00
 (1
.23
–3
.25
)
0.
00
52
2.
19
 (1
.67
–2
.87
)
<
0.
00
01
1.
77
 (1
.34
–2
.35
)
<
0.
00
01
St
ro
ke
 (2
56
)
1.
33
 (0
.53
–3
.33
)
0.
54
3.
06
 (2
.25
–4
.16
)
<
0.
00
01
2.
13
 (1
.55
–2
.92
)
<
0.
00
01
A
m
bu
la
to
ry
 n
or
m
ot
en
sio
n 
is 
th
e 
re
fe
re
nt
 g
ro
up
. A
ll 
m
od
el
s w
er
e 
ad
jus
ted
 fo
r c
oh
ort
, se
x, 
ag
e, 
bo
dy
 m
ass
 in
de
x, 
sm
ok
ing
 an
d d
rin
kin
g, 
ser
um
 ch
ole
ste
rol
, h
ist
ory
 of
 ca
rdi
ov
asc
ula
r d
ise
ase
, a
nd
 di
ab
ete
s 
m
el
lit
us
. T
he
 c
au
se
 o
f d
ea
th
 w
as
 u
nk
no
w
n 
in
 2
3 
ca
se
s.
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Ta
bl
e 
4
M
ul
tiv
ar
ia
bl
e-
A
dju
ste
d S
tan
da
rdi
zed
 H
aza
rd 
Ra
tio
s f
or 
24
-H
ou
r S
yst
oli
c a
nd
 D
ias
tol
ic 
Bl
oo
d P
res
sur
es 
by
 A
ge
 G
rou
p
En
d 
Po
in
t
<
50
 y
ea
rs
 (n
=3
76
1)
≥5
0 
ye
ar
s (
n=
45
80
)
n
D
ia
st
ol
ic
 P
re
ss
ur
e
Sy
st
ol
ic
 P
re
ss
ur
e
n
D
ia
st
ol
ic
 P
re
ss
ur
e
Sy
st
ol
ic
 P
re
ss
ur
e
M
or
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lit
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ta
l
A
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.66
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–1
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21
 (1
.14
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.26
–3
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0.
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 (0
.30
–1
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.94
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Ca
rd
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ul
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.61
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23
 (1
.32
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.85
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51
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.34
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N
on
ca
rd
io
va
sc
ul
ar
A
46
1.
13
 (0
.83
–1
.55
)
0.
93
 (0
.61
–1
.42
)
50
2
1.
06
 (0
.97
–1
.16
)
1.
03
 (0
.94
–1
.12
)
FA
1.
73
 (0
.96
–3
.12
)
0.
53
 (0
.25
–1
.13
)
1.
09
 (0
.95
–1
.25
)
0.
96
 (0
.84
–1
.10
)
Fa
ta
l p
lu
s n
on
fa
ta
l e
ve
nt
s
 
A
ll 
ca
rd
io
va
sc
ul
ar
A
47
1.
65
 (1
.27
–2
.14
)‡
1.
68
 (1
.19
–2
.36
)†
69
7
1.
36
 (1
.27
–1
.46
)‡
1.
44
 (1
.35
–1
.53
)‡
FA
1.
74
 (1
.03
–2
.93
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0.
92
 (0
.47
–1
.81
)
1.
06
 (0
.97
–1
.17
)
1.
39
 (1
.27
–1
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)‡
 
Ca
rd
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c
A
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53
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.12
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)†
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52
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–2
.27
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44
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1.
26
 (1
.16
–1
.38
)‡
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37
 (1
.26
–1
.48
)‡
FA
1.
67
 (0
.92
–3
.03
)
0.
88
 (0
.40
–1
.90
)
1.
01
 (0
.90
–1
.14
)
1.
36
 (1
.22
–1
.52
)‡
 
Co
ro
na
ry
A
28
1.
63
 (1
.16
–2
.30
)†
1.
67
 (1
.07
–2
.62
)*
32
0
1.
25
 (1
.13
–1
.38
)‡
1.
35
 (1
.23
–1
.48
)‡
FA
1.
73
 (0
.87
–3
.45
)
0.
92
 (0
.37
–2
.24
)
1.
01
 (0
.88
–1
.15
)
1.
35
 (1
.18
–1
.53
)‡
 
St
ro
ke
A
7
2.
31
 (1
.25
–4
.27
)†
2.
43
 (1
.12
–5
.26
)*
24
9
1.
61
 (1
.43
–1
.81
)‡
1.
65
 (1
.49
–1
.83
)‡
FA
2.
24
 (0
.62
–8
.20
)
1.
04
 (0
.21
–5
.26
)
1.
14
 (0
.97
–1
.34
)
1.
52
 (1
.32
–1
.76
)‡
n
 in
di
ca
te
s t
he
 n
um
be
r o
f e
ve
nt
s. 
Th
e 
ca
us
e 
of
 d
ea
th
 w
as
 u
nk
no
w
n 
in
 2
3 
ca
se
s. 
H
az
ar
d 
ra
tio
s, 
pr
es
en
te
d 
w
ith
 9
5%
 co
nf
id
en
ce
 in
te
rv
al
, e
xp
re
ss
 th
e r
isk
 as
so
ci
at
ed
 w
ith
 a 
1-
SD
 in
cr
ea
se
 in
 2
4-
ho
ur
 sy
sto
lic
 
(13
.5 
mm
 H
g) 
or 
dia
sto
lic
 (8
.2 
mm
 H
g) 
blo
od
 pr
ess
ure
s. 
Al
l m
od
els
 w
ere
 ad
jus
ted
 fo
r c
oh
ort
, se
x, 
ag
e, 
bo
dy
 m
ass
 in
de
x, 
sm
ok
ing
 an
d d
rin
kin
g, 
ser
um
 ch
ole
ste
rol
, h
ist
ory
 of
 ca
rdi
ov
asc
ula
r d
ise
ase
, a
nd
 
di
ab
et
es
 m
el
lit
us
. A
dju
ste
d m
od
els
 (A
) in
clu
de
 ei
the
r s
yst
oli
c o
r d
ias
tol
ic 
blo
od
 pr
ess
ure
, w
he
rea
s f
ull
y a
dju
ste
d m
od
els
 (F
A)
 in
clu
de
 bo
th 
sys
tol
ic 
an
d d
ias
tol
ic 
blo
od
 pr
ess
ure
s i
n a
dd
itio
n t
o t
he
 
af
or
em
en
tio
ne
d 
co
va
ria
bl
es
. S
ig
ni
fic
an
ce
 o
f t
he
 h
az
ar
d 
ra
tio
s:
*
P≤
0.
05
;
† P
≤0
.0
1,
 a
nd
‡ P
≤0
.0
01
. T
he
 in
te
ra
ct
io
ns
 o
f d
ia
sto
lic
 a
nd
 sy
sto
lic
 p
re
ss
ur
e 
w
ith
 a
ge
 (c
on
tin
uo
us
) i
n f
ull
y a
dju
ste
d m
od
els
 w
ere
 si
gn
ific
an
t o
r b
ord
erl
ine
 si
gn
ific
an
t fo
r c
ard
iov
asc
ula
r m
ort
ali
ty 
(0.
03
6≤
P≤
0.0
58
), a
ll 
ca
rd
io
va
sc
ul
ar
 e
ve
nt
s (
0.0
03
7≤
P≤
0.0
04
8),
 an
d c
oro
na
ry 
ev
en
ts 
(0.
01
2≤
P≤
0.0
43
).
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